Literature DB >> 17212656

Cys669-Cys713 disulfide bridge formation is a key to dystroglycan cleavage and subunit association.

Noriyuki Watanabe1, Toshikuni Sasaoka, Satoru Noguchi, Ichizo Nishino, Torahiko Tanaka.   

Abstract

Dystroglycan (DG) is a widely expressed, transmembrane glycoprotein complex that plays important roles by connecting the extracellular matrix to the cytoskeleton. The alpha- and beta-DG subunits are produced by the cleavage of residues 653 and 654 of the precursor. To clarify the mechanisms involved in cleavage and subunit association, we performed a series of mutation analyses and made the following discoveries: (i) Disruption of the intramolecular disulfide bridge between Cys669 and Cys713 in beta-DG completely abolishes the cleavage, (ii) deletions in the loop region (669-713) and in the C-terminal region of alpha-DG (550-645) abolish the cleavage, (iii) disruption of the disulfide bridge and deletions in the loop region deteriorate the alpha- and beta-DG subunit association, and (iv) at the cleavage site, especially, positions P1' (Ser654) and P6' (Trp659) are critical. Thus, the critical role of the Cys669-Cys713 disulfide bridge formation is, most likely, to form a specific tertiary structure, in which the alpha- and beta-DG domains interact and the cleavage site becomes susceptible to proteolytic reactions. The Cys669 and Cys713 pair is broadly conserved in vertebrates and in some invertebrates, suggesting that the disulfide bridge formation was established early in the evolution of DG.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17212656     DOI: 10.1111/j.1365-2443.2006.01033.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  6 in total

1.  Dystroglycan is associated to the disulfide isomerase ERp57.

Authors:  Francesca Sciandra; Emanuela Angelucci; Fabio Altieri; Daniela Ricci; Wolfgang Hübner; Tamara C Petrucci; Bruno Giardina; Andrea Brancaccio; Manuela Bozzi
Journal:  Exp Cell Res       Date:  2012-07-16       Impact factor: 3.905

2.  The evolution of the dystroglycan complex, a major mediator of muscle integrity.

Authors:  Josephine C Adams; Andrea Brancaccio
Journal:  Biol Open       Date:  2015-08-28       Impact factor: 2.422

3.  biAb Mediated Restoration of the Linkage between Dystroglycan and Laminin-211 as a Therapeutic Approach for α-Dystroglycanopathies.

Authors:  Nathan Gumlaw; Leila M Sevigny; Hongmei Zhao; Zhengyu Luo; Dinesh S Bangari; Elizabeth Masterjohn; Yangde Chen; Barbara McDonald; Maureen Magnay; Tara Travaline; Takako Yoshida-Moriguchi; Wei Fan; David Reczek; James E Stefano; Huawei Qiu; Christian Beil; Christian Lange; Ercole Rao; Michael Lukason; Elizabeth Barry; William H Brondyk; Yunxiang Zhu; Seng H Cheng
Journal:  Mol Ther       Date:  2019-12-06       Impact factor: 11.454

4.  Insertion of a myc-tag within α-dystroglycan domains improves its biochemical and microscopic detection.

Authors:  Simona Morlacchi; Francesca Sciandra; Maria Giulia Bigotti; Manuela Bozzi; Wolfgang Hübner; Antonio Galtieri; Bruno Giardina; Andrea Brancaccio
Journal:  BMC Biochem       Date:  2012-07-26       Impact factor: 4.059

Review 5.  Genetic Engineering of Dystroglycan in Animal Models of Muscular Dystrophy.

Authors:  Francesca Sciandra; Maria Giulia Bigotti; Bruno Giardina; Manuela Bozzi; Andrea Brancaccio
Journal:  Biomed Res Int       Date:  2015-08-24       Impact factor: 3.411

6.  Insights from molecular dynamics simulations: structural basis for the V567D mutation-induced instability of zebrafish alpha-dystroglycan and comparison with the murine model.

Authors:  Davide Pirolli; Francesca Sciandra; Manuela Bozzi; Bruno Giardina; Andrea Brancaccio; Maria Cristina De Rosa
Journal:  PLoS One       Date:  2014-07-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.